(1) Lee J et al. Tumor genomic profiling guides metastatic gastric cancer patients to targeted treatment: The VIKTORY Umbrella Trial. Cancer Discovery July 17, 2019
(2) Sa K et al. (as a co-corresponding author) Comprehensive pharmacogenomics characterization of gastric cancer. Genome Med 2020 feb 18; 12(1): 17
(3) Lim SH et al. (corresponding author) Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening. Front Oncol 2019 9: 1327.
(4) Lee J (corresponding author) Mechanisms of Acquired Resistance to Savolitinib, a Selective MET Inhibitor in MET-amplified Gastric Cancer. JCO Precision Oncology epub 2020/03
(5)Willis J, et al (as a co-senior author). Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel. Clin Cancer Res 2019 Aug 4
(6)Lee JK et al (as a co-corresponding author) Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. Nature Genetics.2018 Oct;50
(7) Kim ST et al (as a co-corresponding author) Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nature Medicine 2018 July 16 epub
(8) Kim ST et al (as a corresponding author) Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2-positive gastric cancer patients. Annals of Oncology. 2018 Apr 1;29(4):1037-1048
(9) Kim ST et al (as a corresponding author) Rapamycin-insensitive companion of mTOR (RICTOR) Amplification Defines a Subset of Advanced Gastric Cancer and is Sensitive to AZD2014-mediated mTORC1/2 Inhibition. Annals of Oncology. 2017 Mar 1;28(3):547-554
(10) Kim ST, et al (as a corresponding author) Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA–Guided Therapy in Refractory Metastatic Solid Cancers: An Interim Analysis. JCO Precision Oncology 2017
(11) Kim ST, Kim KM, Kim NKD, Park JO, Ahn S, Yun JW, Kim KT, Park SH, Park PJ, Kim HC, Sohn TS, Choi DI, Cho JH, Heo JS, Kwon W, Lee H, Min BH, Hong SN, Park YS, Lim HY, Kang WK, Park WY, Lee J. (as a corresponding author) Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials. Oncologist 2017 Oct;22(10):1169-1177
(12) R Cristescu, Lee J, Nebozhyn M, Kim KM et al. (co-first author) Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nature Medicine. 2015 May;21(5):449-56
수상
2020 SKKU Excellence in Research Award 2019 (성균관대학교 의과대학 최우수 연구업적상)